DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Cellectar Biosciences Q4 EPS $(0.33) Down From $0.06 YoY

Cellectar Biosciences (NASDAQ:CLRB) reported quarterly losses of $(0.33) per share. This is a 650 percent decrease over earnings of $0.06 per share from the same period last year.

Benzinga · 03/09/2020 12:03

Cellectar Biosciences (NASDAQ:CLRB) reported quarterly losses of $(0.33) per share. This is a 650 percent decrease over earnings of $0.06 per share from the same period last year.